Better Therapeutics Investor Relations Material

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. The Company's products include a smartphone app that enables real-time management of care; a weekly medication adherence program using pill cap reminder technology; a remote monitoring solution; and patient engagement tools such as text messaging. It offers Meds Adherence Mobile Platform that provides real-time data mining and analytics, as well as video telemedicine services to improve patient engagement and outcomes across the continuum of care.